Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Herbert H F Loong"'
Autor:
Byoung Chul Cho, Herbert H. F. Loong, Chun-Ming Tsai, Man Lung P. Teo, Hye Ryun Kim, Sun Min Lim, Suyog Jain, Steve Olsen, Keunchil Park
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 2154-2164 (2022)
Plasma-based next-generation sequencing (NGS) has demonstrated the potential to guide the personalized treatment of non-small cell lung cancer (NSCLC). Inherent differences in mutational genomic profiles of NSCLC exist between Asian and Western popul
Externí odkaz:
https://doaj.org/article/56e3c7bc762a4cb7a4d8412e5f4fef6d
Autor:
Peter Y. M. Woo, Yi Li, Anna H. Y. Chan, Stephanie C. P. Ng, Herbert H. F. Loong, Danny T. M. Chan, George K. C. Wong, Wai-Sang Poon
Publikováno v:
Glioma, Vol 2, Iss 2, Pp 68-82 (2019)
Temozolomide (TMZ), an oral alkylating agent, is a cornerstone of standard-of-care multimodality therapy for glioblastoma. In spite of significant efforts to treat this disease, the tumor carries a poor prognosis and is considered incurable largely d
Externí odkaz:
https://doaj.org/article/3652e18040d640ffbf90f719b93ec390
Autor:
Peter Y M Woo, Stephen Yau, Tai-Chung Lam, Jenny K S Pu, Lai-Fung Li, Louisa C Y Lui, Danny T M Chan, Herbert H F Loong, Michael W Y Lee, Rebecca Yeung, Carol C H Kwok, Siu-Kie Au, Tze-Ching Tan, Amanda N C Kan, Tony K T Chan, Calvin H K Mak, Henry K F Mak, Jason M K Ho, Ka-Man Cheung, Teresa P K Tse, Sarah S N Lau, Joyce S W Chow, Aya El-Helali, Ho-Keung Ng, Wai-Sang Poon
Publikováno v:
Neuro-Oncology Practice. 10:50-61
Background The aim of this study is to address the paucity of epidemiological data regarding the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma patients. Methods This was a population-level study of Hong Kong adult
Autor:
Winnie Yeo, Frankie K. F. Mo, Elizabeth Pang, Joyce J. S. Suen, Jane Koh, Herbert H. F. Loong, Christopher C. H. Yip, Rita Y. W. Ng, Claudia H. W. Yip, Nelson L. S. Tang, Giok S. Liem
Publikováno v:
BMC Women's Health, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Adjuvant chemotherapy improves outcome of patients with early breast cancer. However, chemotherapy may be associated with long term toxicities. In this retrospective cohort study, the objectives were to determine body weight, body
Externí odkaz:
https://doaj.org/article/665306ae22d54e7aade6c559df47eb28
Autor:
Anthony T. C. Chan, Chi H. Wong, Connie W. C. Hui, Charles M. L. Chan, Anil T. Ahuja, Ki Wang, Ann D. King, Leung Li, Frankie Mo, Herbert H. F. Loong, Brigette B. Y. Ma, Edwin P. Hui
Purpose: We hypothesized that axitinib is active with an improved safety profile in nasopharyngeal carcinoma (NPC).Experimental Design: We evaluated axitinib in preclinical models of NPC and studied its efficacy in a phase II clinical trial in recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b99b5ddf6114538515af6ca4906ec3d
https://doi.org/10.1158/1078-0432.c.6525588
https://doi.org/10.1158/1078-0432.c.6525588
Autor:
Anthony T. C. Chan, Chi H. Wong, Connie W. C. Hui, Charles M. L. Chan, Anil T. Ahuja, Ki Wang, Ann D. King, Leung Li, Frankie Mo, Herbert H. F. Loong, Brigette B. Y. Ma, Edwin P. Hui
Pharmacokinetic profile of axitinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02323118c0004fa22d5ef94a3b97a78c
https://doi.org/10.1158/1078-0432.22463970.v1
https://doi.org/10.1158/1078-0432.22463970.v1
Autor:
Anthony T. C. Chan, Chi H. Wong, Connie W. C. Hui, Charles M. L. Chan, Anil T. Ahuja, Ki Wang, Ann D. King, Leung Li, Frankie Mo, Herbert H. F. Loong, Brigette B. Y. Ma, Edwin P. Hui
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2299fc165c3ffda40d3c879e23cea19e
https://doi.org/10.1158/1078-0432.22463967.v1
https://doi.org/10.1158/1078-0432.22463967.v1
Publikováno v:
Investigational new drugs. 40(4)
Autor:
Kristy T K, Lau, Lui, Ng, Jason W H, Wong, Herbert H F, Loong, Wendy W L, Chan, Chi Ho, Lee, Carlos K H, Wong
Publikováno v:
Reviews in endocrinemetabolic disorders. 22(4)
Developed as an antidiabetic drug, recent evidence suggests that several sodium-glucose co-transporter 2 inhibitors (SGLT2i), especially canagliflozin and dapagliflozin, may exhibit in vitro and in vivo anticancer activities in selected cancer types,
Autor:
Ravi Rajaram, Lynette M. Sholl, Sanja Dacic, Jonathan W. Goldman, Daniel Shao-Weng Tan, Oliver Gautschi, Herbert H. F. Loong, Filippo G. De Braud, Erminia Massarelli, Benjamin Philip Levy, Grace K. Dy, Suhyun Kang, Sylwia Szymczak, Bo H. Chao, Alexander E. Drilon
Publikováno v:
Journal of Clinical Oncology. 40:TPS8594-TPS8594
TPS8594 Background: Despite definitive surgery and perioperative chemotherapy, many patients with locoregional non-small cell lung cancer (NSCLC) continue to experience recurrent disease and limited survival. Although targeted therapies are standard